Haemonetics Corporation Excess Tax Benefit from Share-based Compensation, Financing Activities
Haemonetics Corporation (HAE) reported Excess Tax Benefit from Share-based Compensation, Financing Activities of $0 for the 12-month period ending 2017-04-01, per its 10-K filed 2017-05-24.
Discontinued › Notes › Compensation Related Costs
us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities · last filed 2017-05-24
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2015-03-28 was $1.60M, a 393.83% increase year-over-year.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2014-12-27 was $0.00, a 100.00% decline year-over-year.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2014-09-27 was $0.00, a 100.00% decline year-over-year.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for the quarter ending 2014-06-28 was $0.00, a 100.00% decline year-over-year.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2016 was $1.60M, a 0.00% change from fiscal 2015.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2015 was $1.60M, a 33.33% decline from fiscal 2014.
- Haemonetics Corporation excess tax benefit from share-based compensation, financing activities for fiscal 2014 was $2.40M, a 41.48% decline from fiscal 2013.
| Period end | Excess Tax Benefit from Share-based Compensation, Financing Activities 3 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 6 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 9 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month | Excess Tax Benefit from Share-based Compensation, Financing Activities 12 month as first filed |
|---|---|---|---|---|---|
| 2017-04-01 | $0.00 10-K · filed 2017-05-24 | ||||
| 2016-04-02 | $1.60M 10-K · filed 2017-05-24 | $0.00 10-K · filed 2016-06-01 | |||
| 2015-03-28 | $1.60M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-01 | $1.60M derived: sum of 2 quarters · filed 2016-06-01 | $1.60M derived: sum of 3 quarters · filed 2016-06-01 | $1.60M 10-K · filed 2016-06-01 | $1.57M 10-K · filed 2015-05-22 |
| 2014-12-27 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $0.00 derived: sum of 2 quarters · filed 2015-02-05 | $0.00 10-Q · filed 2015-02-05 | $324.00K derived: sum of 4 quarters · filed 2016-06-01 | |
| 2014-09-27 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-04 | $0.00 10-Q · filed 2014-11-04 | $324.00K derived: sum of 3 quarters · filed 2016-06-01 | $819.00K derived: sum of 4 quarters · filed 2016-06-01 | |
| 2014-06-28 | $0.00 10-Q · filed 2014-07-31 | $324.00K derived: sum of 2 quarters · filed 2016-06-01 | $819.00K derived: sum of 3 quarters · filed 2016-06-01 | $1.44M derived: sum of 4 quarters · filed 2016-06-01 | |
| 2014-03-29 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-01 | $819.00K derived: sum of 2 quarters · filed 2016-06-01 | $1.44M derived: sum of 3 quarters · filed 2016-06-01 | $2.40M 10-K · filed 2016-06-01 | $2.40M 10-K · filed 2014-05-22 |
| 2013-12-28 | $495.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-05 | $1.12M derived: sum of 2 quarters · filed 2015-02-05 | $2.08M 10-Q · filed 2015-02-05 | $3.02M derived: sum of 4 quarters · filed 2015-05-22 | |
| 2013-09-28 | $621.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-04 | $1.58M 10-Q · filed 2013-10-30 | $2.52M derived: sum of 3 quarters · filed 2015-05-22 | $3.60M derived: sum of 4 quarters · filed 2015-05-22 | |
| 2013-06-29 | $960.00K 10-Q · filed 2014-07-31 | $1.90M derived: sum of 2 quarters · filed 2015-05-22 | $2.98M derived: sum of 3 quarters · filed 2015-05-22 | $3.95M derived: sum of 4 quarters · filed 2015-05-22 | |
| 2013-03-30 | $943.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-22 | $2.02M derived: sum of 2 quarters · filed 2015-05-22 | $2.99M derived: sum of 3 quarters · filed 2015-05-22 | $4.10M 10-K · filed 2015-05-22 | |
| 2012-12-29 | $1.08M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-01-30 | $2.05M derived: sum of 2 quarters · filed 2014-01-30 | $3.16M 10-Q · filed 2014-01-30 | $3.75M derived: sum of 4 quarters · filed 2014-05-22 | |
| 2012-09-29 | $968.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-10-30 | $2.08M 10-Q · filed 2013-10-30 | $2.67M derived: sum of 3 quarters · filed 2014-05-22 | $3.18M derived: sum of 4 quarters · filed 2014-05-22 | |
| 2012-06-30 | $1.11M 10-Q · filed 2013-08-02 | $1.71M derived: sum of 2 quarters · filed 2014-05-22 | $2.21M derived: sum of 3 quarters · filed 2014-05-22 | $2.23M derived: sum of 4 quarters · filed 2014-05-22 | |
| 2012-03-31 | $594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-05-22 | $1.10M derived: sum of 2 quarters · filed 2014-05-22 | $1.12M derived: sum of 3 quarters · filed 2014-05-22 | $1.43M 10-K · filed 2014-05-22 | |
| 2011-12-31 | $506.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-02-01 | $526.00K derived: sum of 2 quarters · filed 2013-02-01 | $839.00K 10-Q · filed 2013-02-01 | $2.80M derived: sum of 4 quarters · filed 2013-05-20 | |
| 2011-10-01 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-11-07 | $333.00K 10-Q · filed 2012-11-07 | $2.29M derived: sum of 3 quarters · filed 2013-05-20 | $2.83M derived: sum of 4 quarters · filed 2013-05-20 | |
| 2011-07-02 | $313.00K 10-Q · filed 2012-08-08 | $2.27M derived: sum of 2 quarters · filed 2013-05-20 | $2.81M derived: sum of 3 quarters · filed 2013-05-20 | $2.89M derived: sum of 4 quarters · filed 2013-05-20 | |
| 2011-04-02 | $1.96M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-20 | $2.50M derived: sum of 2 quarters · filed 2013-05-20 | $2.58M derived: sum of 3 quarters · filed 2013-05-20 | $3.12M 10-K · filed 2013-05-20 | |
| 2011-01-01 | $534.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-02-06 | $613.00K derived: sum of 2 quarters · filed 2012-02-06 | $1.16M 10-Q · filed 2012-02-06 | $1.40M derived: sum of 4 quarters · filed 2012-05-22 | |
| 2010-10-02 | $79.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2011-11-03 | $628.00K 10-Q · filed 2011-11-03 | $869.00K derived: sum of 3 quarters · filed 2012-05-22 | $892.00K derived: sum of 4 quarters · filed 2012-05-22 | |
| 2010-07-03 | $549.00K 10-Q · filed 2011-08-10 | $790.00K derived: sum of 2 quarters · filed 2012-05-22 | $813.00K derived: sum of 3 quarters · filed 2012-05-22 | $814.00K derived: sum of 4 quarters · filed 2012-05-22 | |
| 2010-04-03 | $241.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-22 | $264.00K derived: sum of 2 quarters · filed 2012-05-22 | $265.00K derived: sum of 3 quarters · filed 2012-05-22 | $421.00K 10-K · filed 2012-05-22 | |
| 2009-12-26 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-02-08 | $24.00K derived: sum of 2 quarters · filed 2011-02-08 | $180.00K 10-Q · filed 2011-02-08 | ||
| 2009-09-26 | $1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-11-10 | $157.00K 10-Q · filed 2010-11-10 | |||
| 2009-06-27 | $156.00K 10-Q · filed 2010-08-11 | ||||
| 2009-03-28 | $7.47M 10-K · filed 2011-05-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |